期刊文献+

妊娠合并细菌性阴道病两种治疗方法对比分析 被引量:1

Analysis of two kinds of treatment methods in the pregnant women with bacterial vaginosis
在线阅读 下载PDF
导出
摘要 目的:探讨乳酸菌阴道胶囊与奥硝唑栓治疗妊娠合并细菌性阴道病的疗效。方法:将妊娠中期合并细菌性阴道病的妇女180例随机分为两组,各90例,A组为观察组采用乳酸菌阴道胶囊治疗,B组为对照组采用奥硝唑栓治疗,观察治疗1周的痊愈率及停药后1周、1个月的复发率。结果:治疗1周后A、B两组的痊愈率分别是66.67%、68.89%,组间比较无显著性差异(P>0.05);两组停药1周复发率分别为7.78%、6.67%,组间比较无显著性差异(P>0.05);停药1个月复发率分别为4.44%、3.33%,组间比较无显著性差异(P>0.05)。结论:应用乳酸阴道胶囊与奥硝唑栓治疗妊娠合并细菌性阴道病疗效确切,但乳酸菌阴道胶囊为微生态制剂,孕妇易接受。 Objective:To analyze the clinical therapeutic effect of Lacidophilin Vaginal Capsules and Ornidazole Suppositories on bacterial vaginosis in pregnant women.Methods:180 cases of patients with bacterial vaginosis in mid trimester of pregnancy were randomly and averagely divided into the group A and the group B:group A were treated by Lacidophilin Vaginal Capsules;group B were treated by Ornidazole Suppositories,to observe recovery rate after treatment 1 week,and recurrence rate of stop to use the drugs after 1 week and 1 month.Results:after treatment 1 week,recovery rate of the group A and the group B was 66.67%,68.89%,there was no significant difference between the two groups(P0.05),and in the two groups,recurrence rate of stop to use the drugs after 1 week was 7.78%,6.67%,there was no significant difference between the two groups(P0.05),and recurrence rate of stop to use the drugs after 1 month was 4.44%,3.33%,there was no significant difference between the two groups(P0.05).Conclusion:Treatment effectiveness of bacterial vaginosis in pregnant women with Lacidophilin Vaginal Capsules and Ornidazole Suppositories,but Lacidophilin Vaginal Capsule are microecological modulator,the pregnant women are easy to accept.
作者 毛锦芳
出处 《中国医药导报》 CAS 2010年第24期22-23,共2页 China Medical Herald
关键词 妊娠中期 细菌性阴道病 乳酸菌阴道胶囊 奥硝唑栓 Mid trimester of pregnancy Bacterial vaginosis Lacidophilin Vaginal Capsule Ornidazole Suppositories
  • 相关文献

参考文献6

二级参考文献32

  • 1陈秀美.厌氧菌引发细菌性阴道病的临床检验及鉴定[J].国际医药卫生导报,2003,9(12):54-54. 被引量:10
  • 2蒋成时编著.妊娠期、哺乳期用药[M].北京:人民卫生出版社.2000:513
  • 3Kekki M, K - arki T, Kotomaki T et al. Cost - effectiveness of screening and treatment for bacterial vagmosis in early pregnancy among women at low risk for preterm birth. Aeta Obstet Gynecol Stand, 2004, 83(1): 27-36
  • 4Leitich H, Bodner - Adler B, Brunbauer Met al. Bacterial vaglnosis as a risk factor for preterm delivery: a meta- analysis. Am J Obstet Gyneeol. 2003, 189 (1): 139-147
  • 5Yen S, Shafer MA, Moncada Jet al. Bacterial vagmosis m sexually experienced 'and non - sexually experienced young women entering the military. Obstet Gynecol, 2003, 102 (5 pt 1): 927-933
  • 6Wiggins R, Crowley T, Homer PJ et al. Use off - Bromo -4 - Chloro -3 - Indolyl - a - D - N - Acetylneuraminic acid in a novel spot test to identify sialidase activity in vaginal swabs from women with bacterial vaginosis. $ Clin Microbiol, 2000, 38 : 3096 - 3097
  • 7Myziuk L, Romanowski Bet at. BV Blue test for diagnosis of bacterial vaginosis. J Clin Microbial, 2003, 41 (5) : 1925 - 1928
  • 8董悦,赵瑞林.现代妇产科诊疗手册.第2版,北京:北京科技大学出版社,2002:247—249
  • 9Jessica L, Thomason MD, Sheldon Met al. Bacterial Vaginosis - Current review with indications for asymptomatic therapy. Am J Obstet Gyneclo, 1991, 165 (4): 1210
  • 10Briselden AM. Sialidases neuraminidase in bacterial vaginosis and bacterial vaginosis- associated microflora. J Clin Microbiol, 1992, 6 (9) :663

共引文献45

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部